Literature DB >> 9685238

Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of tat-regulated HIV transactivation.

J R Hwu1, W N Tseng, J Gnabre, P Giza, R C Huang.   

Abstract

Nordihydroguaiaretic acid (NDGA, meso-1) possesses four phenolic hydroxyl groups. Treatment of NDGA with 0.50-4.1 equiv of dimethyl sulfate and 3.0-6.0 equiv of potassium carbonate in acetone at 56 degrees C gave nine methylated products. Eight of those mono-, di-, tri-, and tetra-O-methylated NDGAs were isolated in pure form, and their structures were identified unambiguously by spectroscopic methods. A preparative amount of tetramethyl NDGA M4N (10) was obtained in 99% yield from NDGA by use of 4.1 equiv of dimethyl sulfate for the methylation. Among the eight different methylated NDGAs (2-6 and 8-10), tetra-O-methyl-NDGA (10) showed the strongest anti-HIV activity (IC50 11 microM). Chemically synthesized 3'-O-methyl-NDGA ((+/-)-2) showed identical anti-HIV activity (IC50 25 microM) to the lignan isolated from Creosote Bush. Lignans with methylated catecholic hydroxyl groups can be produced in large quantities with low cost. At drug concentrations below 30 microM tetramethyl NDGA (10) was a stronger anti-HIV agent than mono- and dimethylated NDGAs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685238     DOI: 10.1021/jm970819w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

Review 1.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

Review 2.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

3.  Significant biological role of sp1 transactivation in multiple myeloma.

Authors:  Mariateresa Fulciniti; Samir Amin; Puru Nanjappa; Scott Rodig; Rao Prabhala; Cheng Li; Stephane Minvielle; Yu-Tzu Tai; Pierfrancesco Tassone; Herve Avet-Loiseau; Teru Hideshima; Kenneth C Anderson; Nikhil C Munshi
Journal:  Clin Cancer Res       Date:  2011-08-19       Impact factor: 12.531

4.  Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma.

Authors:  Yunguang Sun; Nicholas J Giacalone; Bo Lu
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

5.  Recent Advances on Small-Molecule Survivin Inhibitors

Authors:  Min Xiao; Wei Li
Journal:  Curr Med Chem       Date:  2015-01-13       Impact factor: 4.530

6.  Phase I study of terameprocol in patients with recurrent high-grade glioma.

Authors:  Stuart A Grossman; Xiaobu Ye; David Peereboom; Myrna R Rosenfeld; Tom Mikkelsen; Jeffrey G Supko; Serena Desideri
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

7.  Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression.

Authors:  Chih-Chuan Chang; Jonathan D Heller; Jennifer Kuo; Ru Chih C Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

8.  Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.

Authors:  Ross O Meyers; Joshua D Lambert; Nicole Hajicek; Alan Pourpak; John A Kalaitzis; Robert T Dorr
Journal:  Bioorg Med Chem Lett       Date:  2009-06-21       Impact factor: 2.823

9.  Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-κB-dependent transcription of TNF-α and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA.

Authors:  Akinbolade O Oyegunwa; Michael L Sikes; Jason R Wilson; Frank Scholle; Scott M Laster
Journal:  J Inflamm (Lond)       Date:  2010-12-07       Impact factor: 4.981

10.  Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines.

Authors:  D Eads; Rl Hansen; Ao Oyegunwa; Ce Cecil; Ca Culver; F Scholle; Itd Petty; Sm Laster
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.